» Authors » Wiek H van Gilst

Wiek H van Gilst

Explore the profile of Wiek H van Gilst including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 262
Citations 10636
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pozder C, Screever E, van der Velde A, Sillje H, Suwijn J, de Rond S, et al.
Int J Mol Sci . 2023 Mar; 24(5). PMID: 36901846
Previous studies have reported an association between ABO type blood group and cardiovascular (CV) events and outcomes. The precise mechanisms underpinning this striking observation remain unknown, although differences in von...
2.
Nijholt K, Sanchez-Aguilera P, Booij H, Oberdorf-Maass S, Dokter M, Wolters A, et al.
Sci Rep . 2023 Mar; 13(1):4046. PMID: 36899057
A Kinase Interacting Protein 1 (AKIP1) is a signalling adaptor that promotes physiological hypertrophy in vitro. The purpose of this study is to determine if AKIP1 promotes physiological cardiomyocyte hypertrophy...
3.
Binnenmars S, Hoogslag G, Yeung S, Brouwers F, Bakker S, van Gilst W, et al.
J Am Heart Assoc . 2022 Jul; 11(15):e024952. PMID: 35876420
Background The role of fibroblast growth factor 23 (FGF23) in the development of new-onset heart failure (HF) with reduced (HFrEF) or preserved ejection fraction (HFpEF) in the general population is...
4.
Pozder Geb Gehlken C, van der Velde A, Meijers W, Sillje H, Muntendam P, Dokter M, et al.
Curr Res Transl Med . 2021 Nov; 70(1):103321. PMID: 34826684
Purpose Of The Study: A major challenge in cardiology remains in finding a therapy for cardiac fibrosis. Inhibition of galectin-3 with pectins attenuates fibrosis in animal models of heart failure....
5.
Nijholt K, Meems L, Ruifrok W, Maass A, Yurista S, Pavez-Giani M, et al.
Pflugers Arch . 2021 Jun; 473(8):1301-1313. PMID: 34142210
Erythropoietin (EPO) is a haematopoietic hormone that regulates erythropoiesis, but the EPO-receptor (EpoR) is also expressed in non-haematopoietic tissues. Stimulation of the EpoR in cardiac and skeletal muscle provides protection...
6.
Tromp J, Paniagua S, Lau E, Allen N, Blaha M, Gansevoort R, et al.
BMJ . 2021 Mar; 372:n461. PMID: 33758001
Objective: To assess age differences in risk factors for incident heart failure in the general population. Design: Pooled population based cohort study. Setting: Framingham Heart Study, Prevention of Renal and...
7.
Linschoten M, Peters S, van Smeden M, Jewbali L, Schaap J, Siebelink H, et al.
Eur Heart J Acute Cardiovasc Care . 2020 Nov; 9(8):817-823. PMID: 33222494
Aims: To determine the frequency and pattern of cardiac complications in patients hospitalised with coronavirus disease (COVID-19). Methods And Results: CAPACITY-COVID is an international patient registry established to determine the...
8.
Gommans D, Nas J, Pinto-Sietsma S, Koop Y, Konst R, Mensink F, et al.
Am Heart J . 2020 Jun; 226:60-68. PMID: 32512291
There is much debate on the use of angiotensin receptor blockers (ARBs) in severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2)-infected patients. Although it has been suggested that ARBs might lead to a...
9.
De Jong M, van Roon A, Bakker J, Bijen H, Mulder D, Brouwers F, et al.
J Hypertens . 2020 May; 38(6):1064-1071. PMID: 32371796
Background: Arterial stiffness influences the contour of the digital pressure pulse wave. Method: Here, we investigated whether the digital pulse propagation index (DPPI), based on the digital pressure pulse wave,...
10.
Pearson J, Sipido K, Musialek P, van Gilst W
Cardiovasc Res . 2019 Jul; 115(10):e96-e98. PMID: 31334808
No abstract available.